Figure 3 | Scientific Reports

Figure 3

From: A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics

Figure 3

Effect of ND8008 on the growth and cell morphology of MRSA.

(a) Growth at different concentrations of ND8008, Dex, ISMN or the mixture of dexamethasone and ISMN (Dex + ISMN) (10 to 250 μM) for 16 h in 96-well microtitre plates. Error bars indicate the standard deviation of 3 measurements. (b) TEM images of MRSA with 250/100 μM ND8008 treatment (at 16 h). (c) Growth at 10/25/50 μM ND8008 was monitored over time. ***P < 0.001 versus the control. *P < 0.05 versus the control. The same volume of ethanol was added to the control treatments in place of the drugs.

Back to article page